A Vaccine Made From Your Own Tumour: NeoVax’s Early Ovarian Cancer Test, Explained
A personalised vaccine called NeoVax, built from a patient’s own tumour mutations, was tested with nivolumab in a phase 1 ovarian cancer trial. A careful reading.
Your Calm Guide Through Modern Tech
A personalised vaccine called NeoVax, built from a patient’s own tumour mutations, was tested with nivolumab in a phase 1 ovarian cancer trial. A careful reading.